Eco Science Solutions, Inc.
ESSI
OTC PK
| Weiss Ratings | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -100.45 | |||
| Price History | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | 260.00% | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | 260.00% | |||
| 2-Year Total Return | 260.00% | |||
| 3-Year Total Return | 350.00% | |||
| 5-Year Total Return | -88.00% | |||
| 52-Week High % Change | -99.60% | |||
| 52-Week Low % Change | 179,900.00% | |||
| Price | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.45 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 12, 2024 | |||
| 52-Week High Price (Date) | Feb 11, 2025 | |||
| Valuation | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 95.32K | |||
| Enterprise Value | 8.56M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -22.39% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.01 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -8.36 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 52.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 833 464 3726 | |||
| Address | 300 S. El Camino Real San Clemente, CA 92672 | |||
| Website | www.useherbo.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -618.95% | |||
| Return on Equity | -- | |||
| Income Statement | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.02M | |||
| Net Income (TTM) | -1.10M | |||
| Net Income Avl. to Common (TTM) | -1.10M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 6.52% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 7.14% | |||
| Balance Sheet | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.10K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 4.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -16.28M | |||
| Current Ratio (Q) | 0.000 | |||
| Book Value Per Share (Q) | -$0.31 | |||
| Total Assets (Q) | 104.10K | |||
| Total Current Liabilities (Q) | 16.38M | |||
| Total Debt (Q) | 8.47M | |||
| Total Liabilities (Q) | 16.38M | |||
| Total Common Equity (Q) | -16.28M | |||
| Cash Flow | ESSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 328.10K | |||
| Net Change in Cash (TTM) | 1.70K | |||
| Levered Free Cash Flow (TTM) | 85.40K | |||
| Cash from Operations (TTM) | -326.60K | |||
